Patents by Inventor Mark A. Griffin

Mark A. Griffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132501
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
    Type: Application
    Filed: August 21, 2023
    Publication date: April 25, 2024
    Applicant: Praxis Precision Medicines, Inc.
    Inventors: Andrew Mark Griffin, Brian Edward Marron, Gabriel Martinez Botella
  • Publication number: 20240119394
    Abstract: A computing device and method for preparing application data based on a migration recommendation includes collecting survey responses to categorized questions and assigning a score to each of the survey response. The scored survey responses are normalized and rationalization parameters are determined based on the normalized scores. Application data are prepared for migration based on a recommended disposition determined from the rationalization parameters.
    Type: Application
    Filed: October 3, 2023
    Publication date: April 11, 2024
    Inventors: Mark Candelora, Sara Smiles, Katie Ryan, Ish Haque, Michael Griffin
  • Patent number: 11945826
    Abstract: The present invention relates hydroxypyridoxazepine compounds, methods of making them, pharmaceutical compositions containing them and their use as Nrf2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, or a tautomer thereof, or a hydrate thereof.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: April 2, 2024
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Mark Elban, Michal Pawel Glogowski, Michael Clinton Koetting, Brian Griffin Lawhorn, Jay M. Matthews, Jaclyn Renee Patterson
  • Patent number: 11918571
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: March 5, 2024
    Assignee: Praxis Precision Medicines, Inc.
    Inventors: Kiran Reddy, Gabriel Martinez Botella, Andrew Mark Griffin, Brian Edward Marron
  • Publication number: 20240043415
    Abstract: The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 8, 2024
    Inventors: Andrew Mark GRIFFIN, Gabriel MARTINEZ BOTELLA, Brian Edward MARRON, Ricardo Lira
  • Publication number: 20240043433
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
    Type: Application
    Filed: August 4, 2023
    Publication date: February 8, 2024
    Inventors: Kiran REDDY, Gabriel Martinez Botella, Andrew Mark Griffin, Brian Edward Marron, Carlos Loya
  • Publication number: 20240025852
    Abstract: The present invention is directed to, in part, deuterium-enriched compounds and compositions comprising a deuterium-enriched compound useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel.
    Type: Application
    Filed: November 9, 2021
    Publication date: January 25, 2024
    Inventors: Andrew Mark Griffin, Gabriel Martinez Botella, Jason Labutti
  • Patent number: 11866439
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: January 9, 2024
    Assignee: PRAXIS PRECISION MEDICINES, INC.
    Inventors: Andrew Mark Griffin, Brian Edward Marron, Gabriel Martinez Botella, Kiran Reddy, Marion Wittmann
  • Patent number: 11832019
    Abstract: An image processing method for harmonizing images acquired by a first camera and a second camera connected to a vehicle and arranged in such a way as their fields of view cover a same road space at different times as the vehicle travels along a travel direction is disclosed. The method includes: acquiring by a selected camera, a first image at a first time; selecting a first region of interest bounding a road portion from the first image; sampling the first region of interest; acquiring by the other camera, a second image in such a way that the road portion is included in a second region of interest; sampling the second region of interest; and determining one or more correction parameters for harmonizing images acquired by the first and second cameras, based on a comparison between the image content of the first and second regions of interest.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: November 28, 2023
    Assignee: Connaught Electronics Ltd.
    Inventors: Mark Griffin, Aidan Casey, Emre Turgay, Alex Perkins
  • Publication number: 20230371791
    Abstract: An endoscope system including a first reusable hand-piece and a second reusable hand-piece. The first reusable hand-piece is a different size than the second reusable hand-piece. The first reusable hand-piece and the second reusable hand-piece are selectively attachable and detachable to the same or a different single-use shaft assembly. Varying sizes of reusable hand-piece assemblies provide for improved user ergonomics. Ergonomic variations may include different size reusable hand-piece assemblies, different size articulation control knobs, and/or different distances between the centerline of the housing of the reusable hand-piece and the knobs and/or between the backstrap of the reusable hand-piece and the knobs, customizable to user preference.
    Type: Application
    Filed: May 18, 2023
    Publication date: November 23, 2023
    Applicant: AdaptivEndo LLC
    Inventors: Hershel E. Fancher, Michael W. Goldenbogen, Trevor E. Powers, Galen R. Powers, Mark A. Griffin
  • Publication number: 20230348466
    Abstract: The present invention is directed to, in part, compositions or dosage forms comprising fused heteroaryl compounds useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, neuromuscular disorders, trigeminal autonomic cephalalgia (TAC), migraine, cranial neuropathy or multiple cranial neuropathy, and cortical spreading depression (CSD) are also provided herein. In another aspect, the present invention provides a method of making ion channel modulators.
    Type: Application
    Filed: November 25, 2020
    Publication date: November 2, 2023
    Inventors: Gabriel MARTINEZ BOTELLA, Walter J. LUNSMANN, Sapna Makhija GARAD, David REED, Andrew Mark GRIFFIN, Michael Kristopher Mathieu KAHLIG, Brian Edward MARRON, Carlos LOYA
  • Patent number: 11788241
    Abstract: A road embedded battery includes a first encapsulation layer disposed on top of a road grade base. A first conductor mesh is disposed on top of the first encapsulation layer and an anode material is embedded into to first conductor mesh. A permeable membrane is disposed on top of the anode material. A second conductor mesh is disposed on top of the permeable membrane and a cathode material is embedded into the second conductor mesh. A second encapsulation layer is disposed on top of the cathode material.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 17, 2023
    Assignee: Hunt Energy Enterprises, L.L.C.
    Inventors: Mark Griffin, Fantai Kong
  • Publication number: 20230322790
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
    Type: Application
    Filed: March 10, 2023
    Publication date: October 12, 2023
    Inventors: Kiran Reddy, Gabriel Martinez Botella, Andrew Mark Griffin, Brian Edward Marron
  • Publication number: 20230309802
    Abstract: Endoscope assemblies, systems, and methods of manufacturing same are disclosed. In particular, endoscopes having controls and/or tool port openings one end of an elongate handle and the insertion tube assembly and umbilical extending to the console at another end of the elongate handle are provided. Fluid control and flow path arrangements in the handle of the endoscope are also described as well as configurations for articulation links and constructions for insertion tubes.
    Type: Application
    Filed: June 7, 2023
    Publication date: October 5, 2023
    Applicant: AdaptivEndo LLC
    Inventors: Hershel E. Fancher, Mark A. Griffin, Galen R. Powers, Trevor E. Powers, Michael W. Goldenbogen, Gregory R. Furnish, Nicholas Canfield, Nathan Wallace, Walter Stubblefield
  • Publication number: 20230309796
    Abstract: Arrangements comprising an endoscope system having an endoscope including a reusable hand-piece, a separable single-use shaft assembly, a single-use cartridge and a console are disclosed. Endoscope assemblies having articulation knobs attached by friction fit, multi-stage rotational distance limiters, and/or elevators are disclosed. Components of same, packaging systems, and methods are also provided.
    Type: Application
    Filed: May 23, 2023
    Publication date: October 5, 2023
    Inventors: Hershel E. Fancher, Mark A. Griffin, Michael W. Goldenbogen, Gregory R. Furnish, Nicholas Canfield, Galen R. Powers, Trevor E. Powers, Sumner E. Adams
  • Patent number: 11773099
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. The fused heteroaryl compounds of the disclosure are represented by Formula (I): wherein X, Y, Z, A, R1 and R2 are as defined in the specification. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: October 3, 2023
    Assignee: Praxis Precision Medicines, Inc.
    Inventors: Kiran Reddy, Gabriel Martinez Botella, Andrew Mark Griffin, Brian Edward Marron
  • Patent number: 11773088
    Abstract: The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: October 3, 2023
    Assignee: Praxis Precision Medicines, Inc.
    Inventors: Gabriel Martinez Botella, Andrew Mark Griffin
  • Patent number: 11767325
    Abstract: The present invention is directed to, in part, fused heteroaryl compounds of Formula (II-II): and compositions thereof, useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: September 26, 2023
    Assignee: PRAXIS PRECISION MEDICINES, INC.
    Inventors: Kiran Reddy, Gabriel Martinez Botella, Andrew Mark Griffin, Brian Edward Marron, Carlos Loya
  • Publication number: 20230285377
    Abstract: The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
    Type: Application
    Filed: March 23, 2021
    Publication date: September 14, 2023
    Inventors: Gabriel MARTINEZ BOTELLA, Andrew Mark GRIFFIN
  • Patent number: D1018844
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: March 19, 2024
    Assignee: AdaptivEndo LLC
    Inventors: Hershel E. Fancher, Galen R. Powers, Michael W. Goldenbogen, Mark A. Griffin, Gregory R. Furnish, Trevor E. Powers